Registration is now available for Evidence for Clinical Utility of Molecular Diagnostics in Oncology: A Workshop
Evidence for Clinical Utility of Molecular Diagnostics in Oncology: A Workshop
May 24, 2012
Pew DC Conference Center
Washington, DC
The Center for Medical Technology Policy (CMTP) and the Institute of Medicine’s (IOM) Roundtable on Translating Genomic-Based Research for Health will co-host a workshop with to discuss research methodologies required to demonstrate and assess the clinical validity and clinical utility of molecular diagnostics for oncology. The presentations and discussions will explore the challenges in and identify potential opportunities for advancing the development and use of molecular diagnostic tests that are used to guide the treatment and management of oncology patients. Stakeholders including patients, health care providers, policy makers, payers, diagnostic test developers, researchers, guideline developers, and others will be invited to present their perspectives.
The day-long workshop will be held on May 24, 2012 at the Pew DC Conference Center (Americas Room) • 901 E Street, N.W., Washington, DC 20001. Registration for the event is required through the following website: http://www.iom.edu/Activities/Research/GenomicBasedResearch/2012-MAY-24.aspx
For more information, please contact Merianne Spencer.